SARS-CoV-2-IN-112
SARS-CoV-2-IN-112 (Compound 6f) is an orally active and non-peptidic SARS-CoV-2 main protease inhibitor with an IC50 of 6.48 μM. SARS-CoV-2-IN-11 has potent antiviral activity with low cytotoxicity against WI-38 cells (IC50: 53.81 μM) . SARS-CoV-2-IN-112 can be used for coronaviruses COVID-19 research[1].
Product Specifications
UNSPSC
12352100
Target
SARS-CoV
Related Pathways
Anti-infection
Field of Research
Infection
Smiles
ClC1=CC=C(C=C1)NC(NNC(C2=CC=C(C=C2)NS(=O)(C3=CC=C(C=C3)OC)=O)=O)=S
Molecular Formula
C21H19ClN4O4S2
Molecular Weight
490.98
References & Citations
[1]El-Sayed SM, et al. Tipranavir analogs as antiviral agents: Design, synthesis, in vitro, and in silico study of new SARS-CoV-2 main protease inhibitors. Bioorg Chem. 2025 May 23;163:108624.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC683126-100 1x 100 µL
CD61 / Integrin 3 / Platelet Glycoprotein IIIa (Platelet Marker) (ITGB3/3126R), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
